The Amgen Foundation Inc
- Assets
- $79.4m
- Revenue
- $23.5m
- Investments
- $68.0m
- Employees
- 0
- Location
- Newbury Park, CA
- Founding
- 07/1990
- Data as of
- 12/2022
- EIN
- 77-0252898
Organization Overview
The Amgen Foundation Inc is located in Newbury Park, CA. The organization was established in 1990. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Amgen Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Amgen Foundation Inc generated $23.5m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 4 years, the organization has seen revenues fall by an average of (10.5%) each year. All expenses for the organization totaled $46.8m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Scott Heimlich President | 1 | $0 | |
Ann Hyllengren CFO | 1 | $0 | |
Justin Claeys Treasurer | 1 | $0 | |
Dennis Yai Secretary | 1 | $0 | |
Jim Loper Asst. Secretary | 1 | $0 | |
Andrea Robinson Asst. Secretary | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Daniel J Edelman Inc | 12/30/22 | $1,149,358 |
Substance International | 12/30/22 | $208,344 |
David M Lewis Company Llc | 12/30/22 | $174,693 |
Condon Pr Limited | 12/30/22 | $166,682 |
Allison & Gibb Llp | 12/30/22 | $231,610 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $20,000,000 |
| Interest on Savings | $835,856 |
| Dividends & Interest | $2,413,212 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $251,005 |
| Capital Gain Net Income | $251,005 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $4,487 |
| Total Revenue | $23,504,560 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $46,792 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $1,890 |
| Printing and publications | $0 |
| Other expenses | $2,421,158 |
| Total operating and administrative expenses | $2,891,800 |
| Contributions, gifts, grants paid | $43,878,362 |
| Total expenses and disbursements | $46,770,162 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $10,868,340 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $156,344 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $80 |
| Investments—other | $32,581,710 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $422,263 |
| Total assets | $79,404,479 |
| Accounts payable and accrued expenses | $285,904 |
| Grants payable | $20,413,621 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $3,704,380 |
| Total liabilities | $24,403,905 |
Grants Awarded
Over the last fiscal year, The Amgen Foundation Inc has awarded $34,520,314 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
SEE ATTACHMENT 1 PURPOSE: SEE TR ATTACHMENT (1) | $43,878,362 |
SEE ATTACHMENT 1 CASHACCRUAL DIFF PURPOSE: SEE TR ATTACHMENT (1) | -$9,358,048 |